Global Liposome Drug Delivery Market Insights and Forecast to 2027

Global Liposome Drug Delivery Market Insights and Forecast to 2027

Table of Contents
1 Study Coverage
1.1 Liposome Drug Delivery Product Introduction
1.2 Market by Type
1.2.1 Global Liposome Drug Delivery Market Size Growth Rate by Type
1.4.2 Liposomal Doxorubicin
1.4.3 Liposomal Amphoteracin B
1.2.4 Liposomal Paclitaxel
1.2.5 Others
1.3 Market by Application
1.3.1 Global Liposome Drug Delivery Market Size Growth Rate by Application
1.3.2 Fungal Infection Therapy
1.3.3 Cancer & Tumor Therapy
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Liposome Drug Delivery Sales Estimates and Forecasts 2016-2027
2.2 Global Liposome Drug Delivery Revenue Estimates and Forecasts 2016-2027
2.3 Global Liposome Drug Delivery Revenue by Region: 2016 VS 2021 VS 2027
2.4 Global Top Liposome Drug Delivery Regions by Sales
2.4.1 Global Top Liposome Drug Delivery Regions by Sales (2016-2021)
2.4.2 Global Top Liposome Drug Delivery Regions by Sales (2022-2027)
2.5 Global Top Liposome Drug Delivery Regions by Revenue
2.5.1 Global Top Liposome Drug Delivery Regions by Revenue (2016-2021)
2.5.2 Global Top Liposome Drug Delivery Regions by Revenue (2022-2027)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Liposome Drug Delivery Sales by Manufacturers
3.1.1 Global Top Liposome Drug Delivery Manufacturers by Sales (2016-2021)
3.1.2 Global Top Liposome Drug Delivery Manufacturers Market Share by Sales (2016-2021)
3.1.3 Global Top 10 and Top 5 Companies by Liposome Drug Delivery Sales in 2020
3.2 Global Liposome Drug Delivery Revenue by Manufacturers
3.2.1 Global Top Liposome Drug Delivery Manufacturers by Revenue (2016-2021)
3.2.2 Global Top Liposome Drug Delivery Manufacturers Market Share by Revenue (2016-2021)
3.2.3 Global Top 10 and Top 5 Companies by Liposome Drug Delivery Revenue in 2020
3.3 Global Liposome Drug Delivery Sales Price by Manufacturers
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Liposome Drug Delivery Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Liposome Drug Delivery Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Liposome Drug Delivery Sales by Type
4.1.1 Global Liposome Drug Delivery Historical Sales by Type (2016-2021)
4.1.2 Global Liposome Drug Delivery Forecasted Sales by Type (2022-2027)
4.1.3 Global Liposome Drug Delivery Sales Market Share by Type (2016-2027)
4.2 Global Liposome Drug Delivery Revenue by Type
4.2.1 Global Liposome Drug Delivery Historical Revenue by Type (2016-2021)
4.2.2 Global Liposome Drug Delivery Forecasted Revenue by Type (2022-2027)
4.2.3 Global Liposome Drug Delivery Revenue Market Share by Type (2016-2027)
4.3 Global Liposome Drug Delivery Price by Type
4.3.1 Global Liposome Drug Delivery Price by Type (2016-2021)
4.3.2 Global Liposome Drug Delivery Price Forecast by Type (2022-2027)
5 Market Size by Application
5.1 Global Liposome Drug Delivery Sales by Application
5.1.1 Global Liposome Drug Delivery Historical Sales by Application (2016-2021)
5.1.2 Global Liposome Drug Delivery Forecasted Sales by Application (2022-2027)
5.1.3 Global Liposome Drug Delivery Sales Market Share by Application (2016-2027)
5.2 Global Liposome Drug Delivery Revenue by Application
5.2.1 Global Liposome Drug Delivery Historical Revenue by Application (2016-2021)
5.2.2 Global Liposome Drug Delivery Forecasted Revenue by Application (2022-2027)
5.2.3 Global Liposome Drug Delivery Revenue Market Share by Application (2016-2027)
5.3 Global Liposome Drug Delivery Price by Application
5.3.1 Global Liposome Drug Delivery Price by Application (2016-2021)
5.3.2 Global Liposome Drug Delivery Price Forecast by Application (2022-2027)
6 North America
6.1 North America Liposome Drug Delivery Market Size by Type
6.1.1 North America Liposome Drug Delivery Sales by Type (2016-2027)
6.1.2 North America Liposome Drug Delivery Revenue by Type (2016-2027)
6.2 North America Liposome Drug Delivery Market Size by Application
6.2.1 North America Liposome Drug Delivery Sales by Application (2016-2027)
6.2.2 North America Liposome Drug Delivery Revenue by Application (2016-2027)
6.3 North America Liposome Drug Delivery Market Size by Country
6.3.1 North America Liposome Drug Delivery Sales by Country (2016-2027)
6.3.2 North America Liposome Drug Delivery Revenue by Country (2016-2027)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Liposome Drug Delivery Market Size by Type
7.1.1 Europe Liposome Drug Delivery Sales by Type (2017-2027)
7.1.2 Europe Liposome Drug Delivery Revenue by Type (2017-2027)
7.2 Europe Liposome Drug Delivery Market Size by Application
7.2.1 Europe Liposome Drug Delivery Sales by Application (2017-2027)
7.2.2 Europe Liposome Drug Delivery Revenue by Application (2017-2027)
7.3 Europe Liposome Drug Delivery Market Size by Country
7.3.1 Europe Liposome Drug Delivery Sales by Country (2017-2027)
7.3.2 Europe Liposome Drug Delivery Revenue by Country (2017-2027)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Liposome Drug Delivery Market Size by Type
8.1.1 Asia Pacific Liposome Drug Delivery Sales by Type (2018-2027)
8.1.2 Asia Pacific Liposome Drug Delivery Revenue by Type (2018-2027)
8.2 Asia Pacific Liposome Drug Delivery Market Size by Application
8.2.1 Asia Pacific Liposome Drug Delivery Sales by Application (2018-2027)
8.2.2 Asia Pacific Liposome Drug Delivery Revenue by Application (2018-2027)
8.3 Asia Pacific Liposome Drug Delivery Market Size by Region
8.3.1 Asia Pacific Liposome Drug Delivery Sales by Region (2018-2027)
8.3.2 Asia Pacific Liposome Drug Delivery Revenue by Region (2018-2027)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Liposome Drug Delivery Market Size by Type
9.1.1 Latin America Liposome Drug Delivery Sales by Type (2019-2027)
9.1.2 Latin America Liposome Drug Delivery Revenue by Type (2019-2027)
9.2 Latin America Liposome Drug Delivery Market Size by Application
9.2.1 Latin America Liposome Drug Delivery Sales by Application (2019-2027)
9.2.2 Latin America Liposome Drug Delivery Revenue by Application (2019-2027)
9.3 Latin America Liposome Drug Delivery Market Size by Country
9.3.1 Latin America Liposome Drug Delivery Sales by Country (2019-2027)
9.3.2 Latin America Liposome Drug Delivery Revenue by Country (2019-2027)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
6 Middle East and Africa
6.1 Middle East and Africa Liposome Drug Delivery Market Size by Type
6.1.1 Middle East and Africa Liposome Drug Delivery Sales by Type (2016-2027)
6.1.2 Middle East and Africa Liposome Drug Delivery Revenue by Type (2016-2027)
6.2 Middle East and Africa Liposome Drug Delivery Market Size by Application
6.2.1 Middle East and Africa Liposome Drug Delivery Sales by Application (2016-2027)
6.2.2 Middle East and Africa Liposome Drug Delivery Revenue by Application (2016-2027)
6.3 Middle East and Africa Liposome Drug Delivery Market Size by Country
6.3.1 Middle East and Africa Liposome Drug Delivery Sales by Country (2016-2027)
6.3.2 Middle East and Africa Liposome Drug Delivery Revenue by Country (2016-2027)
6.3.3 Turkey
6.3.4 Saudi Arabia
6.3.5 U.A.E
11 Company Profiles
11.1 Gilead Sciences
11.1.1 Gilead Sciences Corporation Information
11.1.2 Gilead Sciences Overview
11.1.3 Gilead Sciences Liposome Drug Delivery Sales, Price, Revenue and Gross Margin (2016-2021)
11.1.4 Gilead Sciences Liposome Drug Delivery Product Description
11.1.5 Gilead Sciences Related Developments
11.2 Pacira
11.2.1 Pacira Corporation Information
11.2.2 Pacira Overview
11.2.3 Pacira Liposome Drug Delivery Sales, Price, Revenue and Gross Margin (2016-2021)
11.2.4 Pacira Liposome Drug Delivery Product Description
11.2.5 Pacira Related Developments
11.3 Sun Pharmaceutical
11.3.1 Sun Pharmaceutical Corporation Information
11.3.2 Sun Pharmaceutical Overview
11.3.3 Sun Pharmaceutical Liposome Drug Delivery Sales, Price, Revenue and Gross Margin (2016-2021)
11.3.4 Sun Pharmaceutical Liposome Drug Delivery Product Description
11.3.5 Sun Pharmaceutical Related Developments
11.4 Johnson & Johnson
11.4.1 Johnson & Johnson Corporation Information
11.4.2 Johnson & Johnson Overview
11.4.3 Johnson & Johnson Liposome Drug Delivery Sales, Price, Revenue and Gross Margin (2016-2021)
11.4.4 Johnson & Johnson Liposome Drug Delivery Product Description
11.4.5 Johnson & Johnson Related Developments
11.5 Luye Pharma
11.5.1 Luye Pharma Corporation Information
11.5.2 Luye Pharma Overview
11.5.3 Luye Pharma Liposome Drug Delivery Sales, Price, Revenue and Gross Margin (2016-2021)
11.5.4 Luye Pharma Liposome Drug Delivery Product Description
11.5.5 Luye Pharma Related Developments
11.6 Sigma-Tau
11.6.1 Sigma-Tau Corporation Information
11.6.2 Sigma-Tau Overview
11.6.3 Sigma-Tau Liposome Drug Delivery Sales, Price, Revenue and Gross Margin (2016-2021)
11.6.4 Sigma-Tau Liposome Drug Delivery Product Description
11.6.5 Sigma-Tau Related Developments
11.7 Ipsen (Onivyde)
11.7.1 Ipsen (Onivyde) Corporation Information
11.7.2 Ipsen (Onivyde) Overview
11.7.3 Ipsen (Onivyde) Liposome Drug Delivery Sales, Price, Revenue and Gross Margin (2016-2021)
11.7.4 Ipsen (Onivyde) Liposome Drug Delivery Product Description
11.7.5 Ipsen (Onivyde) Related Developments
11.8 CSPC
11.8.1 CSPC Corporation Information
11.8.2 CSPC Overview
11.8.3 CSPC Liposome Drug Delivery Sales, Price, Revenue and Gross Margin (2016-2021)
11.8.4 CSPC Liposome Drug Delivery Product Description
11.8.5 CSPC Related Developments
11.9 Teva Pharmaceutical
11.9.1 Teva Pharmaceutical Corporation Information
11.9.2 Teva Pharmaceutical Overview
11.9.3 Teva Pharmaceutical Liposome Drug Delivery Sales, Price, Revenue and Gross Margin (2016-2021)
11.9.4 Teva Pharmaceutical Liposome Drug Delivery Product Description
11.9.5 Teva Pharmaceutical Related Developments
11.10 Novartis
11.10.1 Novartis Corporation Information
11.10.2 Novartis Overview
11.10.3 Novartis Liposome Drug Delivery Sales, Price, Revenue and Gross Margin (2016-2021)
11.10.4 Novartis Liposome Drug Delivery Product Description
11.10.5 Novartis Related Developments
11.1 Gilead Sciences
11.1.1 Gilead Sciences Corporation Information
11.1.2 Gilead Sciences Overview
11.1.3 Gilead Sciences Liposome Drug Delivery Sales, Price, Revenue and Gross Margin (2016-2021)
11.1.4 Gilead Sciences Liposome Drug Delivery Product Description
11.1.5 Gilead Sciences Related Developments
12 Value Chain and Sales Channels Analysis
12.1 Liposome Drug Delivery Value Chain Analysis
12.2 Liposome Drug Delivery Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Liposome Drug Delivery Production Mode & Process
12.4 Liposome Drug Delivery Sales and Marketing
12.4.1 Liposome Drug Delivery Sales Channels
12.4.2 Liposome Drug Delivery Distributors
12.5 Liposome Drug Delivery Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Liposome Drug Delivery Industry Trends
13.2 Liposome Drug Delivery Market Drivers
13.3 Liposome Drug Delivery Market Challenges
13.4 Liposome Drug Delivery Market Restraints
14 Key Findings in The Global Liposome Drug Delivery Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Liposome Drug Delivery Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of Liposomal Doxorubicin
Table 3. Major Manufacturers of Liposomal Amphoteracin B
Table 4. Major Manufacturers of Liposomal Paclitaxel
Table 5. Major Manufacturers of Others
Table 6. Global Liposome Drug Delivery Market Size Growth Rate by Application, 2016 VS 2021 VS 2027 (US$ Million)
Table 7. Global Liposome Drug Delivery Revenue by Region: 2016 VS 2021 VS 2027 (US$ Million)
Table 8. Global Liposome Drug Delivery Sales by Region (2016-2021) & (K Vial)
Table 9. Global Liposome Drug Delivery Sales Market Share by Region (2016-2021)
Table 10. Global Liposome Drug Delivery Sales by Region (2016-2021) & (K Vial)
Table 11. Global Liposome Drug Delivery Sales Market Share by Region (2022-2027)
Table 12. Global Liposome Drug Delivery Revenue by Region (2016-2021) & (US$ Million)
Table 13. Global Liposome Drug Delivery Revenue Market Share by Region (2016-2021)
Table 14. Global Liposome Drug Delivery Revenue by Region (2022-2027) & (US$ Million)
Table 15. Global Liposome Drug Delivery Revenue Market Share by Region (2022-2027)
Table 16. Global Liposome Drug Delivery Sales by Manufacturers (2016-2021) & (K Vial)
Table 17. Global Liposome Drug Delivery Sales Share by Manufacturers (2016-2021)
Table 18. Global Liposome Drug Delivery Revenue by Manufacturers (2016-2021) & (US$ Million)
Table 19. Global Liposome Drug Delivery Revenue Share by Manufacturers (2016-2021)
Table 20. Liposome Drug Delivery Price by Manufacturers 2016-2021 (USD/Vial)
Table 21. Global Liposome Drug Delivery Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Liposome Drug Delivery by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Liposome Drug Delivery as of 2020)
Table 23. Liposome Drug Delivery Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers Liposome Drug Delivery Product Offered
Table 25. Date of Manufacturers Enter into Liposome Drug Delivery Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Liposome Drug Delivery Sales by Type (2016-2021) & (K Vial)
Table 28. Global Liposome Drug Delivery Sales by Type (2022-2027) & (K Vial)
Table 29. Global Liposome Drug Delivery Sales Share by Type (2016-2021)
Table 30. Global Liposome Drug Delivery Sales Share by Type (2022-2027)
Table 31. Global Liposome Drug Delivery Revenue by Type (2016-2021) & (US$ Million)
Table 32. Global Liposome Drug Delivery Revenue by Type (2022-2027) & (US$ Million)
Table 33. Global Liposome Drug Delivery Revenue Share by Type (2016-2021)
Table 34. Global Liposome Drug Delivery Revenue Share by Type (2022-2027)
Table 35. Liposome Drug Delivery Price by Type (2016-2021) & (USD/Vial)
Table 36. Global Liposome Drug Delivery Price Forecast by Type (2022-2027) & (USD/Vial)
Table 37. Global Liposome Drug Delivery Sales by Application (2016-2021) & (K Vial)
Table 38. Global Liposome Drug Delivery Sales by Application (2022-2027) & (K Vial)
Table 39. Global Liposome Drug Delivery Sales Share by Application (2016-2021)
Table 40. Global Liposome Drug Delivery Sales Share by Application (2022-2027)
Table 41. Global Liposome Drug Delivery Revenue by Application (2016-2021) & (US$ Million)
Table 42. Global Liposome Drug Delivery Revenue by Application (2022-2027) & (US$ Million)
Table 43. Global Liposome Drug Delivery Revenue Share by Application (2016-2021)
Table 44. Global Liposome Drug Delivery Revenue Share by Application (2022-2027)
Table 45. Liposome Drug Delivery Price by Application (2016-2021) & (USD/Vial)
Table 46. Global Liposome Drug Delivery Price Forecast by Application (2022-2027) & (USD/Vial)
Table 47. North America Liposome Drug Delivery Sales by Type (2016-2021) & (K Vial)
Table 48. North America Liposome Drug Delivery Sales by Type (2022-2027) & (K Vial)
Table 49. North America Liposome Drug Delivery Revenue by Type (2016-2021) & (US$ Million)
Table 50. North America Liposome Drug Delivery Revenue by Type (2022-2027) & (US$ Million)
Table 51. North America Liposome Drug Delivery Sales by Application (2016-2021) & (K Vial)
Table 52. North America Liposome Drug Delivery Sales by Application (2022-2027) & (K Vial)
Table 53. North America Liposome Drug Delivery Revenue by Application (2016-2021) & (US$ Million)
Table 54. North America Liposome Drug Delivery Revenue by Application (2022-2027) & (US$ Million)
Table 55. North America Liposome Drug Delivery Sales by Country (2016-2021) & (K Vial)
Table 56. North America Liposome Drug Delivery Sales by Country (2022-2027) & (K Vial)
Table 57. North America Liposome Drug Delivery Revenue by Country (2016-2021) & (US$ Million)
Table 58. North America Liposome Drug Delivery Revenue by Country (2022-2027) & (US$ Million)
Table 59. Europe Liposome Drug Delivery Sales by Type (2016-2021) & (K Vial)
Table 60. Europe Liposome Drug Delivery Sales by Type (2022-2027) & (K Vial)
Table 61. Europe Liposome Drug Delivery Revenue by Type (2016-2021) & (US$ Million)
Table 62. Europe Liposome Drug Delivery Revenue by Type (2022-2027) & (US$ Million)
Table 63. Europe Liposome Drug Delivery Sales by Application (2016-2021) & (K Vial)
Table 64. Europe Liposome Drug Delivery Sales by Application (2022-2027) & (K Vial)
Table 65. Europe Liposome Drug Delivery Revenue by Application (2016-2021) & (US$ Million)
Table 66. Europe Liposome Drug Delivery Revenue by Application (2022-2027) & (US$ Million)
Table 67. Europe Liposome Drug Delivery Sales by Country (2016-2021) & (K Vial)
Table 68. Europe Liposome Drug Delivery Sales by Country (2022-2027) & (K Vial)
Table 69. Europe Liposome Drug Delivery Revenue by Country (2016-2021) & (US$ Million)
Table 70. Europe Liposome Drug Delivery Revenue by Country (2022-2027) & (US$ Million)
Table 71. Asia Pacific Liposome Drug Delivery Sales by Type (2016-2021) & (K Vial)
Table 72. Asia Pacific Liposome Drug Delivery Sales by Type (2022-2027) & (K Vial)
Table 73. Asia Pacific Liposome Drug Delivery Revenue by Type (2016-2021) & (US$ Million)
Table 74. Asia Pacific Liposome Drug Delivery Revenue by Type (2022-2027) & (US$ Million)
Table 75. Asia Pacific Liposome Drug Delivery Sales by Application (2016-2021) & (K Vial)
Table 76. Asia Pacific Liposome Drug Delivery Sales by Application (2022-2027) & (K Vial)
Table 77. Asia Pacific Liposome Drug Delivery Revenue by Application (2016-2021) & (US$ Million)
Table 78. Asia Pacific Liposome Drug Delivery Revenue by Application (2022-2027) & (US$ Million)
Table 79. Asia Pacific Liposome Drug Delivery Sales by Region (2016-2021) & (K Vial)
Table 80. Asia Pacific Liposome Drug Delivery Sales by Region (2022-2027) & (K Vial)
Table 81. Asia Pacific Liposome Drug Delivery Revenue by Region (2016-2021) & (US$ Million)
Table 82. Asia Pacific Liposome Drug Delivery Revenue by Region (2022-2027) & (US$ Million)
Table 83. Latin America Liposome Drug Delivery Sales by Type (2016-2021) & (K Vial)
Table 84. Latin America Liposome Drug Delivery Sales by Type (2022-2027) & (K Vial)
Table 85. Latin America Liposome Drug Delivery Revenue by Type (2016-2021) & (US$ Million)
Table 86. Latin America Liposome Drug Delivery Revenue by Type (2022-2027) & (US$ Million)
Table 87. Latin America Liposome Drug Delivery Sales by Application (2016-2021) & (K Vial)
Table 88. Latin America Liposome Drug Delivery Sales by Application (2022-2027) & (K Vial)
Table 89. Latin America Liposome Drug Delivery Revenue by Application (2016-2021) & (US$ Million)
Table 90. Latin America Liposome Drug Delivery Revenue by Application (2022-2027) & (US$ Million)
Table 91. Latin America Liposome Drug Delivery Sales by Country (2016-2021) & (K Vial)
Table 92. Latin America Liposome Drug Delivery Sales by Country (2022-2027) & (K Vial)
Table 93. Latin America Liposome Drug Delivery Revenue by Country (2016-2021) & (US$ Million)
Table 94. Latin America Liposome Drug Delivery Revenue by Country (2022-2027) & (US$ Million)
Table 95. Middle East and Africa Liposome Drug Delivery Sales by Type (2016-2021) & (K Vial)
Table 96. Middle East and Africa Liposome Drug Delivery Sales by Type (2022-2027) & (K Vial)
Table 97. Middle East and Africa Liposome Drug Delivery Revenue by Type (2016-2021) & (US$ Million)
Table 98. Middle East and Africa Liposome Drug Delivery Revenue by Type (2022-2027) & (US$ Million)
Table 99. Middle East and Africa Liposome Drug Delivery Sales by Application (2016-2021) & (K Vial)
Table 100. Middle East and Africa Liposome Drug Delivery Sales by Application (2022-2027) & (K Vial)
Table 101. Middle East and Africa Liposome Drug Delivery Revenue by Application (2016-2021) & (US$ Million)
Table 102. Middle East and Africa Liposome Drug Delivery Revenue by Application (2022-2027) & (US$ Million)
Table 103. Middle East and Africa Liposome Drug Delivery Sales by Country (2016-2021) & (K Vial)
Table 104. Middle East and Africa Liposome Drug Delivery Sales by Country (2022-2027) & (K Vial)
Table 105. Middle East and Africa Liposome Drug Delivery Revenue by Country (2016-2021) & (US$ Million)
Table 106. Middle East and Africa Liposome Drug Delivery Revenue by Country (2022-2027) & (US$ Million)
Table 107. Gilead Sciences Corporation Information
Table 108. Gilead Sciences Description and Major Businesses
Table 109. Gilead Sciences Liposome Drug Delivery Sales (K Vial), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2016-2021)
Table 110. Gilead Sciences Liposome Drug Delivery Product
Table 111. Gilead Sciences Recent Developments
Table 112. Pacira Corporation Information
Table 113. Pacira Description and Major Businesses
Table 114. Pacira Liposome Drug Delivery Sales (K Vial), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2016-2021)
Table 115. Pacira Liposome Drug Delivery Product
Table 116. Pacira Recent Developments
Table 117. Sun Pharmaceutical Corporation Information
Table 118. Sun Pharmaceutical Description and Major Businesses
Table 119. Sun Pharmaceutical Liposome Drug Delivery Sales (K Vial), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2016-2021)
Table 120. Sun Pharmaceutical Liposome Drug Delivery Product
Table 121. Sun Pharmaceutical Recent Developments
Table 122. Johnson & Johnson Corporation Information
Table 123. Johnson & Johnson Description and Major Businesses
Table 124. Johnson & Johnson Liposome Drug Delivery Sales (K Vial), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2016-2021)
Table 125. Johnson & Johnson Liposome Drug Delivery Product
Table 126. Johnson & Johnson Recent Developments
Table 127. Luye Pharma Corporation Information
Table 128. Luye Pharma Description and Major Businesses
Table 129. Luye Pharma Liposome Drug Delivery Sales (K Vial), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2016-2021)
Table 130. Luye Pharma Liposome Drug Delivery Product
Table 131. Luye Pharma Recent Developments
Table 132. Sigma-Tau Corporation Information
Table 133. Sigma-Tau Description and Major Businesses
Table 134. Sigma-Tau Liposome Drug Delivery Sales (K Vial), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2016-2021)
Table 135. Sigma-Tau Liposome Drug Delivery Product
Table 136. Sigma-Tau Recent Developments
Table 137. Ipsen (Onivyde) Corporation Information
Table 138. Ipsen (Onivyde) Description and Major Businesses
Table 139. Ipsen (Onivyde) Liposome Drug Delivery Sales (K Vial), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2016-2021)
Table 140. Ipsen (Onivyde) Liposome Drug Delivery Product
Table 141. Ipsen (Onivyde) Recent Developments
Table 142. CSPC Corporation Information
Table 143. CSPC Description and Major Businesses
Table 144. CSPC Liposome Drug Delivery Sales (K Vial), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2016-2021)
Table 145. CSPC Liposome Drug Delivery Product
Table 146. CSPC Recent Developments
Table 147. Teva Pharmaceutical Corporation Information
Table 148. Teva Pharmaceutical Description and Major Businesses
Table 149. Teva Pharmaceutical Liposome Drug Delivery Sales (K Vial), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2016-2021)
Table 150. Teva Pharmaceutical Liposome Drug Delivery Product
Table 151. Teva Pharmaceutical Recent Developments
Table 152. Novartis Corporation Information
Table 153. Novartis Description and Major Businesses
Table 154. Novartis Liposome Drug Delivery Sales (K Vial), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2016-2021)
Table 155. Novartis Liposome Drug Delivery Product
Table 156. Novartis Recent Developments
Table 157. Fudan-Zhangjiang Corporation Information
Table 158. Fudan-Zhangjiang Description and Major Businesses
Table 159. Fudan-Zhangjiang Liposome Drug Delivery Sales (K Vial), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2016-2021)
Table 160. Fudan-Zhangjiang Liposome Drug Delivery Product
Table 161. Fudan-Zhangjiang Recent Developments
Table 162. Key Raw Materials Lists
Table 163. Raw Materials Key Suppliers Lists
Table 164. Liposome Drug Delivery Distributors List
Table 165. Liposome Drug Delivery Customers List
Table 166. Liposome Drug Delivery Market Trends
Table 167. Liposome Drug Delivery Market Drivers
Table 168. Liposome Drug Delivery Market Challenges
Table 169. Liposome Drug Delivery Market Restraints
Table 170. Research Programs/Design for This Report
Table 171. Key Data Information from Secondary Sources
Table 172. Key Data Information from Primary Sources
List of Figures
Figure 1. Liposome Drug Delivery Product Picture
Figure 2. Global Liposome Drug Delivery Market Share by Type in 2020 & 2027
Figure 3. Liposomal Doxorubicin Product Picture
Figure 4. Liposomal Amphoteracin B Product Picture
Figure 5. Liposomal Paclitaxel Product Picture
Figure 6. Others Product Picture
Figure 7. Global Liposome Drug Delivery Sales Market Share by Application in 2020 & 2027
Figure 8. Fungal Infection Therapy
Figure 9. Cancer & Tumor Therapy
Figure 10. Others
Figure 11. Liposome Drug Delivery Report Years Considered
Figure 12. Global Liposome Drug Delivery Sales 2016-2027 (K Vial)
Figure 13. Global Liposome Drug Delivery Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Liposome Drug Delivery Revenue 2016-2027 (US$ Million)
Figure 15. Global Liposome Drug Delivery Revenue Market Share by Region in Percentage: 2020 Versus 2027
Figure 16. Global Liposome Drug Delivery Sales Market Share by Region (2016-2021)
Figure 17. Global Liposome Drug Delivery Sales Market Share by Region (2022-2027)
Figure 18. North America Liposome Drug Delivery Sales YoY (2016-2027) & (K Vial)
Figure 19. North America Liposome Drug Delivery Revenue YoY (2016-2027) & (US$ Million)
Figure 20. Europe Liposome Drug Delivery Sales YoY (2016-2027) & (K Vial)
Figure 21. Europe Liposome Drug Delivery Revenue YoY (2016-2027) & (US$ Million)
Figure 22. Asia-Pacific Liposome Drug Delivery Sales YoY (2016-2027) & (K Vial)
Figure 23. Asia-Pacific Liposome Drug Delivery Revenue YoY (2016-2027) & (US$ Million)
Figure 24. Latin America Liposome Drug Delivery Sales YoY (2016-2027) & (K Vial)
Figure 25. Latin America Liposome Drug Delivery Revenue YoY (2016-2027) & (US$ Million)
Figure 26. Middle East & Africa Liposome Drug Delivery Sales YoY (2016-2027) & (K Vial)
Figure 27. Middle East & Africa Liposome Drug Delivery Revenue YoY (2016-2027) & (US$ Million)
Figure 28. The Top 10 and Top 5 Players Market Share by Liposome Drug Delivery Sales in 2020
Figure 29. The Top 10 and Top 5 Players Market Share by Liposome Drug Delivery Revenue in 2020
Figure 30. Liposome Drug Delivery Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2016 VS 2020
Figure 31. Global Liposome Drug Delivery Sales Market Share by Type (2016-2027)
Figure 32. Global Liposome Drug Delivery Revenue Market Share by Type (2016-2027)
Figure 33. Global Liposome Drug Delivery Sales Market Share by Application (2016-2027)
Figure 34. Global Liposome Drug Delivery Revenue Market Share by Application (2016-2027)
Figure 35. North America Liposome Drug Delivery Sales Market Share by Type (2016-2027)
Figure 36. North America Liposome Drug Delivery Revenue Market Share by Type (2016-2027)
Figure 37. North America Liposome Drug Delivery Sales Market Share by Application (2016-2027)
Figure 38. North America Liposome Drug Delivery Revenue Market Share by Application (2016-2027)
Figure 39. North America Liposome Drug Delivery Sales Share by Country (2016-2027)
Figure 40. North America Liposome Drug Delivery Revenue Share by Country (2016-2027)
Figure 41. U.S. Liposome Drug Delivery Revenue (2016-2027) & (US$ Million)
Figure 42. Canada Liposome Drug Delivery Revenue (2016-2027) & (US$ Million)
Figure 43. Europe Liposome Drug Delivery Sales Market Share by Type (2016-2027)
Figure 44. Europe Liposome Drug Delivery Revenue Market Share by Type (2016-2027)
Figure 45. Europe Liposome Drug Delivery Sales Market Share by Application (2016-2027)
Figure 46. Europe Liposome Drug Delivery Revenue Market Share by Application (2016-2027)
Figure 47. Europe Liposome Drug Delivery Sales Share by Country (2016-2027)
Figure 48. Europe Liposome Drug Delivery Revenue Share by Country (2016-2027)
Figure 49. Germany Liposome Drug Delivery Revenue (2016-2027) & (US$ Million)
Figure 50. France Liposome Drug Delivery Revenue (2016-2027) & (US$ Million)
Figure 51. U.K. Liposome Drug Delivery Revenue (2016-2027) & (US$ Million)
Figure 52. Italy Liposome Drug Delivery Revenue (2016-2027) & (US$ Million)
Figure 53. Russia Liposome Drug Delivery Revenue (2016-2027) & (US$ Million)
Figure 54. Asia Pacific Liposome Drug Delivery Sales Market Share by Type (2016-2027)
Figure 55. Asia Pacific Liposome Drug Delivery Revenue Market Share by Type (2016-2027)
Figure 56. Asia Pacific Liposome Drug Delivery Sales Market Share by Application (2016-2027)
Figure 57. Asia Pacific Liposome Drug Delivery Revenue Market Share by Application (2016-2027)
Figure 58. Asia Pacific Liposome Drug Delivery Sales Share by Region (2016-2027)
Figure 59. Asia Pacific Liposome Drug Delivery Revenue Share by Region (2016-2027)
Figure 60. China Liposome Drug Delivery Revenue (2016-2027) & (US$ Million)
Figure 61. Japan Liposome Drug Delivery Revenue (2016-2027) & (US$ Million)
Figure 62. South Korea Liposome Drug Delivery Revenue (2016-2027) & (US$ Million)
Figure 63. India Liposome Drug Delivery Revenue (2016-2027) & (US$ Million)
Figu

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Gold Nanoparticles Market Research Report 2024

Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 121

Gold nanoparticles are particles with diameters in The 1-100nm range and have unique optical and physical properties. These unique optical-electronics properties have been researched and utilized in high technology applications such as organic photovoltaics, sensory probes, therapeutic agents, drug delivery in biological and medical applications, electronic conductors and catalysis. The optical and electronic properties of gold nanoparticles are tunable by changing The size, shape, surface chemi......

Global High Volume Subcutaneous Drug Delivery Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 04-Jan-2024        Price: US 3380 Onwards        Pages: 109

Market Overview of Global High Volume Subcutaneous Drug Delivery market: According to our latest research, the global High Volume Subcutaneous Drug Delivery market looks promising in the next 5 years. As of 2022, the global High Volume Subcutaneous Drug Delivery market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a dee......

Global Gold Nanoparticles Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 134

According to our LPI (LP Information) latest study, the global Gold Nanoparticles market size was valued at US$ 86 million in 2023. With growing demand in downstream market, the Gold Nanoparticles is forecast to a readjusted size of US$ 200.8 million by 2030 with a CAGR of 12.9% during review period. The research report highlights the growth potential of the global Gold Nanoparticles market. Gold Nanoparticles are expected to show stable growth in the future market. However, product diff......

Global Liposome Drug Delivery Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 123

According to our LPI (LP Information) latest study, the global Liposome Drug Delivery market size was valued at US$ 3652.8 million in 2023. With growing demand in downstream market, the Liposome Drug Delivery is forecast to a readjusted size of US$ 8742.8 million by 2030 with a CAGR of 13.3% during review period. The research report highlights the growth potential of the global Liposome Drug Delivery market. Liposome Drug Delivery are expected to show stable growth in the future market. ......

Global Transdermal Drug Delivery System Market Growth (Status and Outlook) 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 127

According to our LPI (LP Information) latest study, the global Transdermal Drug Delivery System market size was valued at US$ 14730 million in 2023. With growing demand in downstream market, the Transdermal Drug Delivery System is forecast to a readjusted size of US$ 36410 million by 2030 with a CAGR of 13.8% during review period. The research report highlights the growth potential of the global Transdermal Drug Delivery System market. Transdermal Drug Delivery System are expected to sho......

Global Liposomes Drug Delivery Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 117

According to our LPI (LP Information) latest study, the global Liposomes Drug Delivery market size was valued at US$ 3262.7 million in 2023. With growing demand in downstream market, the Liposomes Drug Delivery is forecast to a readjusted size of US$ 6510.7 million by 2030 with a CAGR of 10.4% during review period. The research report highlights the growth potential of the global Liposomes Drug Delivery market. Liposomes Drug Delivery are expected to show stable growth in the future mark......

Global Gold Nanoparticles Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 129

According to our (Global Info Research) latest study, the global Gold Nanoparticles market size was valued at USD 91 million in 2023 and is forecast to a readjusted size of USD 198.5 million by 2030 with a CAGR of 11.9% during review period. Gold nanoparticles are particles with diameters in the 1-100nm range and have unique optical and physical properties. These unique optical-electronics properties have been researched and utilized in high technology applications such as organic photov......

Global Polymers Drug Delivery Market Research Report 2023, Forecast to 2028

Published: 27-Dec-2023        Price: US 2680 Onwards        Pages: 160

Polymeric drug delivery system has defined as a formulation or a device that enables the introduction of a therapeutic substance into the body. It improves its safety and efficacy by controlling the rate, time, and place of release of drugs in the body. Polymeric drug delivery system has defined as a formulation or a device that enables the introduction of a therapeutic substance into the body. It improves its safety and efficacy by controlling the rate, time, and place of release of drug......

Global Polymers Drug Delivery Professional Survey Report 2023, Forecast to 2028

Published: 27-Dec-2023        Price: US 3280 Onwards        Pages: 135

Polymeric drug delivery system has defined as a formulation or a device that enables the introduction of a therapeutic substance into the body. It improves its safety and efficacy by controlling the rate, time, and place of release of drugs in the body. Polymeric drug delivery system has defined as a formulation or a device that enables the introduction of a therapeutic substance into the body. It improves its safety and efficacy by controlling the rate, time, and place of release of drug......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs